148 related articles for article (PubMed ID: 22732422)
21. CYP2D6 in the metabolism of opioids for mild to moderate pain.
Leppert W
Pharmacology; 2011; 87(5-6):274-85. PubMed ID: 21494059
[TBL] [Abstract][Full Text] [Related]
22. The application of genomic and molecular data in the treatment of chronic cancer pain.
Turabi A; Plunkett AR
J Surg Oncol; 2012 Apr; 105(5):494-501. PubMed ID: 22441902
[TBL] [Abstract][Full Text] [Related]
23. Pharmacogenetics in perioperative medicine.
Cohen M; Sadhasivam S; Vinks AA
Curr Opin Anaesthesiol; 2012 Aug; 25(4):419-27. PubMed ID: 22673786
[TBL] [Abstract][Full Text] [Related]
24. Pain research. Why other people may not feel your pain.
Marx J
Science; 2004 Jul; 305(5682):328. PubMed ID: 15256651
[No Abstract] [Full Text] [Related]
25. Pharmacogenomics for personalized pain medicine.
Ko TM; Wong CS; Wu JY; Chen YT
Acta Anaesthesiol Taiwan; 2016 Mar; 54(1):24-30. PubMed ID: 26976339
[TBL] [Abstract][Full Text] [Related]
26. Genetic variation and response to morphine in cancer patients: catechol-O-methyltransferase and multidrug resistance-1 gene polymorphisms are associated with central side effects.
Ross JR; Riley J; Taegetmeyer AB; Sato H; Gretton S; du Bois RM; Welsh KI
Cancer; 2008 Mar; 112(6):1390-403. PubMed ID: 18257092
[TBL] [Abstract][Full Text] [Related]
27. Clinical implications of opioid pharmacogenetics.
Argoff CE
Clin J Pain; 2010 Jan; 26 Suppl 10():S16-20. PubMed ID: 20026961
[TBL] [Abstract][Full Text] [Related]
28. Is target opioid therapy within sight?
Finco G; Pintor M; Sanna D; Orrù G; Musu M; De Conno F; Marchi A; Paribello F; D'Aloja E
Minerva Anestesiol; 2012 Apr; 78(4):462-72. PubMed ID: 22310188
[TBL] [Abstract][Full Text] [Related]
29. Molecular Basis of Cancer Pain Management: An Updated Review.
V Subramaniam A; Salem Yehya AH; Oon CE
Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31547335
[TBL] [Abstract][Full Text] [Related]
30. Genetic mutations that prevent pain: implications for future pain medication.
Oertel B; Lötsch J
Pharmacogenomics; 2008 Feb; 9(2):179-94. PubMed ID: 18370847
[TBL] [Abstract][Full Text] [Related]
31. The antinociceptive effect and adverse drug reactions of oxycodone in human experimental pain in relation to genetic variations in the OPRM1 and ABCB1 genes.
Zwisler ST; Enggaard TP; Noehr-Jensen L; Mikkelsen S; Verstuyft C; Becquemont L; Sindrup SH; Brosen K
Fundam Clin Pharmacol; 2010 Aug; 24(4):517-24. PubMed ID: 19845769
[TBL] [Abstract][Full Text] [Related]
32. Modulation of the central nervous effects of levomethadone by genetic polymorphisms potentially affecting its metabolism, distribution, and drug action.
Lötsch J; Skarke C; Wieting J; Oertel BG; Schmidt H; Brockmöller J; Geisslinger G
Clin Pharmacol Ther; 2006 Jan; 79(1):72-89. PubMed ID: 16413243
[TBL] [Abstract][Full Text] [Related]
33. Predicted activity of UGT2B7, ABCB1, OPRM1, and COMT using full-gene haplotypes and their association with the CYP2D6-inferred metabolizer phenotype.
Wendt FR; Sajantila A; Budowle B
Forensic Sci Int Genet; 2018 Mar; 33():48-58. PubMed ID: 29190510
[TBL] [Abstract][Full Text] [Related]
34. Personalized medicine--one size fits one: tailoring pain therapy to individuals' needs.
Ahmedzai SH
J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):83-5. PubMed ID: 23527673
[TBL] [Abstract][Full Text] [Related]
35. Pain management in the 21st century: utilization of pharmacogenomics and therapeutic drug monitoring.
Jannetto PJ; Bratanow NC
Expert Opin Drug Metab Toxicol; 2011 Jun; 7(6):745-52. PubMed ID: 21585291
[TBL] [Abstract][Full Text] [Related]
36. [Genetic variation-- important for the clinical effect of opioids?].
Klepstad P; Dale O; Borchgrevink PC; Kaasa S; Skorpen F
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2655-8. PubMed ID: 16215614
[TBL] [Abstract][Full Text] [Related]
37. Are mu-opioid receptor polymorphisms important for clinical opioid therapy?
Lötsch J; Geisslinger G
Trends Mol Med; 2005 Feb; 11(2):82-9. PubMed ID: 15694871
[TBL] [Abstract][Full Text] [Related]
38. [Pain and genetics].
Møller AT; Kølvraa S; Jensen TS
Ugeskr Laeger; 2006 May; 168(20):1944-7. PubMed ID: 16768888
[TBL] [Abstract][Full Text] [Related]
39. A genetic association study of the functional A118G polymorphism of the human mu-opioid receptor gene in patients with acute and chronic pain.
Janicki PK; Schuler G; Francis D; Bohr A; Gordin V; Jarzembowski T; Ruiz-Velasco V; Mets B
Anesth Analg; 2006 Oct; 103(4):1011-7. PubMed ID: 17000822
[TBL] [Abstract][Full Text] [Related]
40. Opioid genetics in the context of opioid switching.
Droney J; Riley J; Ross J
Curr Opin Support Palliat Care; 2012 Mar; 6(1):10-6. PubMed ID: 22228031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
